Bortezomib Reddy contains bortezomib, a proteasome inhibitor that helps destroy cancer cells by affecting cell function and growth.
The usual starting dose of bortezomib is 1.3 mg per square meter of body surface, given twice a week.
This medicine is given as an injection into a vein or under the skin by a healthcare professional. Injections into a vein are quick, and injections under the skin are given in the thigh or abdomen.
Typically one dose per day on the scheduled treatment days.